Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


The effect of Ketamine in combination with Dexmedetomidine or Fentanyl on measures of cognition, sedation and behaviour in healthy adults


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12617000787381

Organisation Name: Monash Medical Centre

Overal Status: Completed

Start Date: 18/07/2017

Brief Summary: Both alone and in combination, the effects of Ketamine, Fentanyl and Dexmedetomidine are effective at providing analgesia to patients in the ICU. However, these drug combinations can potentially also have very important consequences for tasks involving complex cognitive and behavioural ability, which includes making important clinical decisions (in a clinical setting both during and post-treatment), and driving a car (post treatment discharge). Currently, it is unclear which clinically indicated drug combination (either KET/DEX or KET/FENT) has more favourable effects on sedation, alertness and cognitive/neurobehavioral outcomes.

We therefore seek to test whether sub-anaesthetic KET/DEX combination will yield in better analgesic and alertness level when compared to KET/FENT, and if there are any differences in cognitive and neurobehavioral abilities between these drug conditions.

Countries:
  • Australia
Conditions:
  • Drugged Driving
  • Acute care
  • Neurocognition


Total execution time in seconds: 0.17468214035034